⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DNTH News
Dianthus Therapeutics, Inc. Common Stock
Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
globenewswire.com
DNTH
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DNTH
Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
globenewswire.com
DNTH
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DNTH
Dianthus Therapeutics to Participate in Three Investor Conferences During September
globenewswire.com
DNTH
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
globenewswire.com
AGMB
DNTH
CRSP
Form 8-K
sec.gov
DNTH
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
globenewswire.com
DNTH
Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
globenewswire.com
DNTH
Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
globenewswire.com
DNTH